Browse Drug Recalls

138 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 138 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 138 FDA drug recalls.

Clear
DateProductReasonClassFirm
Oct 13, 2025 Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg... Subpotent drug; Clavulanate Potassium component Class II Teva Pharmaceuticals USA, Inc
Oct 7, 2025 Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHA... CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Po... Class II Teva Pharmaceuticals USA, Inc
Oct 7, 2025 Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHA... CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Po... Class II Teva Pharmaceuticals USA, Inc
Oct 7, 2025 Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHA... CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Po... Class II Teva Pharmaceuticals USA, Inc
Jan 10, 2025 Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syrin... Failed Stability Specifications - 12-month stability test result for one of the known peptides is... Class II Teva Pharmaceuticals USA, Inc
Jul 2, 2024 PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorba... Defective container: potential for non-sealed pouches which can lead to product leakage. Class III Novel Laboratories, Inc. d.b.a Lupin Somerset
Jun 28, 2024 Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, ... Failed Impurities/Degradation Specifications: Product is being recalled due to API related substa... Class II Teva Pharmaceuticals USA, Inc
Jun 4, 2024 Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-co... Subpotent Drug Class II Teva Pharmaceuticals USA, Inc
Mar 28, 2024 Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx O... Superpotent Drug: The 3-month stability result for assay was found to be above specification limit Class II Teva Pharmaceuticals USA, Inc
Jan 25, 2024 Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic reg... Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. Class III Teva Pharmaceuticals USA, Inc
Jan 25, 2024 Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in... Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. Class III Teva Pharmaceuticals USA, Inc
Nov 10, 2023 Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose pack... OOS for viscosity Class III Teva Pharmaceuticals USA, Inc
Jul 5, 2023 Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured B... Failed Moisture Limits: Water (moisture) content above the approved product specifications. Class II Teva Pharmaceuticals USA Inc
Mar 27, 2023 Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 3... Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A. Class III Teva Pharmaceuticals USA Inc
Feb 23, 2023 Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx ... Packaging defect: observed packaging defect, blister packaging inadequately sealed. Class II The Harvard Drug Group
Aug 29, 2022 Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfat... Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually... Class II Teva Pharmaceuticals USA Inc
May 18, 2022 Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Cart... Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtaine... Class III Teva Pharmaceuticals USA Inc
May 11, 2022 Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in... Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability tes... Class I Teva Pharmaceuticals USA Inc
Feb 4, 2022 PARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton togethe... Non-sterility Class I CooperSurgical, Inc
Jan 26, 2022 AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), M... CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage co... Class II CARDINAL HEALTHCARE
Jan 26, 2022 Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx O... CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage co... Class II CARDINAL HEALTHCARE
Jan 26, 2022 ESTRADIOL TABLETS USP, 0.5MG 100 Tablets, Tx Only, Teva Pharmaceuticals USA, ... CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage co... Class II CARDINAL HEALTHCARE
Jan 10, 2022 Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals US... Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution. Class II Teva Pharmaceuticals USA
Dec 31, 2021 Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Dec 31, 2021 MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 1... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Dec 16, 2021 Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) ... Subpotent Class II Teva Pharmaceuticals USA
Dec 8, 2021 Brinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottl... Defective Container: The notch in the cap that fits into the nozzle of the dropper could break of... Class II Teva Pharmaceuticals USA
Oct 27, 2021 Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx... Labelling: Incorrect Exp. Date Class II Teva Pharmaceuticals USA
Jul 29, 2021 Alprostadil Injection USP, 500 mg/mL, 1 mL single dose, vials, 5 mL single us... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Jul 29, 2021 Haloperidol Decanoate Injection 100 mg/mL, packaged in a) 1 mL single-dose vi... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Jul 29, 2021 Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, ... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Jul 29, 2021 Idarubicin Hydrochloride Injection 20 mg/20 mL, 20 mL single-dose vial, Rx on... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Jul 29, 2021 Methylprednisolone Acetate Injectable Suspension USP, 80 mg/mL, packaged in a... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Jul 29, 2021 Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Jul 29, 2021 Epoprostenol Sodium for Injection, 1.5 mg/vial, 10 mL vials, Rx only, Teva Ph... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Jun 18, 2021 Topotecan Injection 4 mg/4mL (1 mg/mL), Single-Dose vial, Teva Pharmaceutical... Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. ... Class I Teva Pharmaceuticals USA
Apr 26, 2021 Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, 10 mL Multipl... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Apr 26, 2021 Leucovorin Calcium for Injection, equivalent to leucovorin 350 mg/vial (20 mg... Lack of Assurance of Sterility Class II Teva Pharmaceuticals USA
Mar 15, 2021 EPINEPHRINE INJECTION USP, 0.3MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (A... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 15, 2021 EPINEPHRINE INJECTION USP, 0.15 MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES ... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 15, 2021 PENICILLIN V POT for Oral Solution, USP 125mg/5mL 100mL (when mixed) Rx Only... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 15, 2021 Balziva 28 Day (norethindrone and ethinyl estradiol tablets USP) 6 Blister C... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 15, 2021 BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS 2.5 mg/6.25 mg, 100-count... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 15, 2021 NEOMYCIN SULF TABLETS, USP, 500mg, 100-count bottle, Rx Only, Distributed by:... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 4, 2021 Romidepsin Injecton, 27.5 mg/5.5 mL (5 mg/mL) Rx Only, 5.5 ml vial, Teva Phar... Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities... Class III Teva Pharmaceuticals USA
Feb 10, 2021 MethyIPREDNISolone Acetate Injectable Suspension USP, 200 mg/5 mL (0 mg/mL), ... Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... Class II Teva Pharmaceuticals USA
Feb 10, 2021 Leucovorin Calcium for Injection, USP, 350 mg/vial, Rx only, labeled as a) Te... Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... Class II Teva Pharmaceuticals USA
Feb 10, 2021 MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/10 mL (40 mg/mL)... Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... Class II Teva Pharmaceuticals USA
Feb 10, 2021 MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL),... Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... Class II Teva Pharmaceuticals USA
Feb 10, 2021 Epoprostenol Sodium for Injection, 0.5 mg/vial (500,000 ng), 1X10ML vial, Rx... Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... Class II Teva Pharmaceuticals USA

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.